Week in Review, April 6, 2015
West Virginia repeals its disclosure law, Connecticut modifies its requirements for insurance coverage related to off-label use, two whistleblowers file a suit against Teva, and tighter transparency...
View ArticleNews Week in Review, April 13, 2015
Spain and Malaysia amend their anticorruption laws, researchers from the NIH say the government rules on paperwork and travel are too complex, and India considers dedicated oversight for medical...
View ArticleWeek in Review, April 21, 2015
CMS tries to clarify the Open Payments review and dispute process, GSK considers changing its compensation program, and a Florida pharmaceutical manufacturing company is charges with selling unapproved...
View ArticleWeek in Review, April 27, 2015
Teva settles a pay-for-delay case, the FDA migrates toward electronic submission of promotional materials, a circuit court rejects off-label claims against Medtronic, and several states introduce...
View ArticleWeek in Review, May 6, 2015
Connecticut delays the implementation date for its the APRN reporting law, CMS releases 2013 Medicare Part D data, the Medicines Australia Code of Conduct is approved, and lawmakers release draft...
View ArticleWeek in Review, May 13, 2015
European Medicines Agency changes its conflicts of interest policy, ACCME updates its requirements related to the disclosure of commercial support, Siemens may be facing corruption charges in China,...
View ArticleCompliance News in Review, May 20, 2015
New York introduces a drug price disclosure law, a judge dismisses a deceptive marketing lawsuit against four painkiller manufacturers, a new survey shows the public still holds the pharmaceutical...
View ArticleCompliance News in Review, May 27, 2015
Legislation nullifying the need to report payments associated with CME moves to the House of Representatives for a vote, a new article in the NEJM offers thought proving insight on the relationship...
View ArticleCompliance News in Review, June 5, 2015
Cephalon settles a generics case with the FTC over its sleep disorder drug and the OIG releases its mid-year update to its 2015 Work Plan, and we offer our take on how it impacts training. Well, the...
View ArticleCompliance News in Review, June 16, 2015
Dinosaurs roamed the earth again (at least in the land of movie theaters), over the weekend, with the release of the summer’s first big blockbuster, Jurassic World. You’d think after three films, the...
View ArticleLooking Ahead: CBI’s 9th Annual Forum on Transparency and Aggregate Spend
The release of the first full year of data under the Open Payments Program is just around the corner, which naturally means transparency and aggregate spend are top of mind these days. Will the data be...
View ArticleCompliance News in Review, June 29, 2015
The universe has spoken – summer is officially here. (If you’re living in a part of the country that is in the midst of a heatwave, I’m sure you’re thinking “never mind what the calendar says, summer...
View ArticleCompliance News in Review, July 2, 2015
A former medical device CEO is sentence to two years in prison, the House of Representatives moves on the exemption of payments for CME, textbooks and medical literature under Sunshine, a Connecticut...
View ArticleCompliance News in Review, July 10, 2015
The government targets Novartis for False Claims violations, pharmaceutical companies map out a plan to keep medication flowing into Greece throughout the crisis, and the industry as a whole ponders...
View ArticleCompliance News in Review, July 20, 2015
The House of Representatives passes the 21st Century Cures Act, two companies settle AMP charges, oral arguments begin in Amarin v. FDA, and CMS updates its Open Payments FAQs. Diamonds are not only a...
View ArticleCompliance News in Review, August 3, 2015
There was a rare occurrence in the skies this weekend. Hopefully you weren’t standing alone without a dream in your heart when it happened, but if so, there’s a wonderful song by The Marcels that can...
View ArticleNews in Review, August 11, 2015
Industry support of CME increases in 2014, NuVasive settles False Claims charges while Mead Johnson deals with FCPA charges, and Amarin wins a preliminary injunction in its off-label case against the...
View ArticleCBI’s 9th Annual Forum on Transparency and Aggregate Spend: A Review
CBI’s recent Forum on Transparency and Aggregate Spend covered a variety of topics affecting the collection and reporting of aggregate spend data. The conference featured speakers from industry,...
View ArticleCompliance News in Review, October 5, 2015
CMS releases a new teaching hospital list and de minimis thresholds, ICD-10 is launched, New Hampshire investigates manufacturers of painkillers, and the UK Ministry of Justice reverses its position on...
View ArticleCompliance News in Review, October 14, 2015
A survey of physicians in the UK reveals negative opinions of the pharmaceutical industry, another pharmaceutical company settles kickback allegations with the DOJ, BMS enters into an FCPA settlement,...
View Article